Results 251 to 260 of about 12,626,738 (303)
Some of the next articles are maybe not open access.
Hepatitis B Vaccination Safety
Annals of Pharmacotherapy, 2002BACKGROUND: Recent studies have suggested that adult hepatitis B vaccination may be associated with adverse reactions. OBJECTIVE: To further examine the relative risk, percentage association, and statistical significance of arthritic ...
Mark R, Geier, David A, Geier
openaire +2 more sources
Vaccine, 2003
The status and likely impact of existing and potential new combined hepatitis B vaccines were broadly considered at the Viral Hepatitis Prevention Board (VHPB) meeting in Malta, October 2001. The currently available and/or licensed combined hepatitis B vaccines in Europe and the prospects for further such vaccines were reviewed.
FitzSimons, D. +3 more
openaire +3 more sources
The status and likely impact of existing and potential new combined hepatitis B vaccines were broadly considered at the Viral Hepatitis Prevention Board (VHPB) meeting in Malta, October 2001. The currently available and/or licensed combined hepatitis B vaccines in Europe and the prospects for further such vaccines were reviewed.
FitzSimons, D. +3 more
openaire +3 more sources
Indications for Hepatitis B Vaccine
JAMA: The Journal of the American Medical Association, 1982To the Editor.— I wish to take exception to some of Dr Saul Krugman's recommendations for the use of hepatitis B vaccine (1982;247:2012). I believe that he has defined too broadly the high-risk groups who should now receive this unusually expensive vaccine, which, initially, will probably be limited in availability.
openaire +2 more sources
A review of hepatitis B vaccination
Expert Opinion on Drug Safety, 2003Hepatitis B is one of the most important infectious causes of acute and chronic liver disease both in the US and worldwide. In order to combat the life-threatening effects of hepatitis B infection, recombinant hepatitis B vaccines have been developed.
Mark R, Geier +2 more
openaire +2 more sources
The Nurse Practitioner, 1983
Hepatitis B is a major public health problem. Complications of the disease can include a carrier state, chronic active hepatitis, cirrhosis and hepatocellular carcinoma. The development of hepatitis B virus vaccine has made active immunization against HBV possible.
openaire +2 more sources
Hepatitis B is a major public health problem. Complications of the disease can include a carrier state, chronic active hepatitis, cirrhosis and hepatocellular carcinoma. The development of hepatitis B virus vaccine has made active immunization against HBV possible.
openaire +2 more sources
2017
Hepatitis A is a liver disease caused by the hepatitis A virus (HAV). The incubation period of hepatitis A is usually 14–28 days. Symptoms of hepatitis A range from mild to severe, and can include fever, malaise, loss of appetite, diarrhea, nausea, abdominal discomfort, dark-colored urine, and jaundice (a yellowing of the skin and whites of the eyes ...
openaire +1 more source
Hepatitis A is a liver disease caused by the hepatitis A virus (HAV). The incubation period of hepatitis A is usually 14–28 days. Symptoms of hepatitis A range from mild to severe, and can include fever, malaise, loss of appetite, diarrhea, nausea, abdominal discomfort, dark-colored urine, and jaundice (a yellowing of the skin and whites of the eyes ...
openaire +1 more source
Combined hepatitis A and B vaccines
Drug and Therapeutics Bulletin, 1997Within the last decade, the development of effective monovalent vaccines has provided a major advance in the prevention of both hepatitis A and B. We have previously reviewed these vaccines.1,2 Now, combined (bivalent) hepatitis A and B vaccines have been licensed (▼Twinrix Adult and ▼Twinrix Paediatric-SmithKline Beecham).
openaire +2 more sources
Experience with hepatitis B vaccine
Medical Journal of Australia, 1986Christopher J ...
openaire +3 more sources